Catalyst Wire Dossier Catalyst Wire Dossier

WO 2707 MoistCream Cremolum

WO 2707 MoistCream Cremolum · Dr. August Wolff GmbH & Co. KG Arzneimittel
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WO 2707 MoistCream Cremolum, covering 2022-04-27 to 2022-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness [Phase 4]

See pricing